John Armitage's CME Position Overview
John Armitage (via Egerton Capital (Uk) Llp) currently holds 1.18 M shares of CME Group Inc. (CME) worth $322.18 M, representing 3.50% of the portfolio. First purchased in 2020-Q4, this short-term holding has been held for 8 quarters.
Based on 13F filings, John Armitage has maintained this position in CME for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2024, adding 964,421 shares. Largest reduction occurred in Q2 2021, reducing 449,800 shares.
Analysis based on 13F filings available since 2013 Q2
John Armitage's CME Group (CME) Holding Value Over Time
Track share changes against reported price movement
Quarterly CME Group (CME) Trades by John Armitage
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -4,996 | Reduce 0.42% | 1.18 M | $273.08 |
| Q3 2025 | -338,148 | Reduce 22.20% | 1.18 M | $270.19 |
| Q2 2025 | -207,258 | Reduce 11.98% | 1.52 M | $275.62 |
| Q1 2025 | +765,773 | Add 79.40% | 1.73 M | $265.29 |
| Q4 2024 | +964,421 | New Buy | 964,421 | $232.23 |
| Q2 2021 | -449,800 | Sold Out | 0 | $0.00 |
| Q1 2021 | -449 | Reduce 0.10% | 449,800 | $204.23 |
| Q4 2020 | +450,249 | New Buy | 450,249 | $182.05 |
John Armitage's CME Group Investment FAQs
John Armitage first purchased CME Group Inc. (CME) in Q4 2020, acquiring 450,249 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Armitage has held CME Group Inc. (CME) for 8 quarters since Q4 2020.
John Armitage's largest addition to CME Group Inc. (CME) was in Q4 2024, adding 964,421 shares worth $223.97 M.
According to the latest 13F filing for Q4 2025, John Armitage's firm, Egerton Capital (Uk) Llp, owns 1,179,792 shares of CME Group Inc. (CME), valued at approximately $322.18 M.
As of the Q4 2025 filing, CME Group Inc. (CME) represents approximately 3.50% of John Armitage's publicly disclosed stock portfolio, making it one of their key holdings.
John Armitage's peak holding in CME Group Inc. (CME) was 1,730,194 shares, as reported at the end of Q1 2025.